Fibrosis progression in chronic hepatitis C virus infection.
about
HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.Hepatitis C virus induces the cannabinoid receptor 1.Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?Predicting the probable outcome of treatment in HCV patients.Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C.Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.Insulin resistance and steatosis in hepatitis C virus infection.Hepatitis C virus infection and nonalcoholic steatohepatitisReview article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis.Tumor necrosis factor-α -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients.Basic answers to complicated questions for the course of chronic hepatitis C treatment.Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis.Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.Treatment of hepatitis C virus infection in intravenous drug users.Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon/ribavirin therapy.A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.Effects of the dihydrolipoyl histidinate zinc complex against carbon tetrachloride-induced hepatic fibrosis in rats.
P2860
Q27468911-F173152F-7F06-4E0D-9599-75F5D1419378Q27478329-E6FE72C0-599D-45F9-8C6A-2FAF94DDADA6Q30244361-8E47D87A-83A9-4E6A-A9CD-E9DF0C19CAEFQ30416248-EF7A910C-DE9D-438E-A7B2-CAD391E1CE32Q33700418-C365FB13-288E-4627-8C7A-056A1341F508Q34163417-0A376205-121C-46F8-BF8F-6FC025F78DB4Q34409039-09E61FE5-2375-488C-9A18-C7689C1177A1Q34537906-D446A238-87C5-47C9-A9DB-867D7271869DQ35965881-11A87E9F-DBBC-47DC-8D90-1F6FE5A2C15AQ36160709-B0C46DC4-5D0A-444A-8209-105D8656A43EQ36179898-ACD8BD9B-EB26-4941-BFAB-6EC0A3C1973FQ36286308-56891B20-1564-4022-B85D-E8AD7597D148Q37242781-E3A38885-1E4A-400F-899A-ED8D2305DDCEQ38014499-D3DEECA0-29ED-4E27-9998-4FDB7EDB90B5Q38157936-A42CA6FC-34E8-4049-BBA6-C31B4F03972DQ38572687-F8D7F215-9370-4675-8BAB-82DC454A895DQ38726664-F0078D5D-8360-4906-8843-14C5EBF33F36Q38779490-F2FBCC67-4679-43A5-B35B-57C7AEA6F4F0Q39450494-143E7518-B167-4C51-AD64-96721C3F9426Q42230670-C9A25A3F-A464-4542-BD9F-DDEFF0861F55Q43292659-7B371EAE-1955-4B4E-BA00-E34F14BFAB12Q53086763-B9240DF2-ED86-4D26-A8D1-7B6DE1F9F6B1
P2860
Fibrosis progression in chronic hepatitis C virus infection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Fibrosis progression in chronic hepatitis C virus infection.
@ast
Fibrosis progression in chronic hepatitis C virus infection.
@en
type
label
Fibrosis progression in chronic hepatitis C virus infection.
@ast
Fibrosis progression in chronic hepatitis C virus infection.
@en
prefLabel
Fibrosis progression in chronic hepatitis C virus infection.
@ast
Fibrosis progression in chronic hepatitis C virus infection.
@en
P2860
P356
P1433
P1476
Fibrosis progression in chronic hepatitis C virus infection.
@en
P2093
G W McCaughan
P2860
P304
P356
10.1136/GUT.2003.026393
P407
P577
2004-03-01T00:00:00Z